Beauty Farm Medical and Health Industry Inc.

XC5 · F · Healthcare / Medical Care Facilities

2.36EUR+0.28 (+13.46%)

Price History

Full chart

Market Stats

Previous Close2.08

Open2.36

Day Range2.36 – 2.36

52-Week Range1.60 – 3.88

Volume0

Market Cap473.01M

P/E (TTM)9.55

Forward P/E0.00

EPS0.20

Dividend Yield4.16%

Beta1.32

50-Day Avg1.95

200-Day Avg2.15

About

Beauty Farm Medical and Health Industry Inc. provides beauty and health management services in the People's Republic of China. It offers aesthetic medical, and subhealth assessment medical services; and intervention services. The company markets its products under the Beauty Farm, Palaispa, Neology, and CellCare brand names. The company was founded in 1993 and is headquartered in Shanghai, the People's Republic of China.

Company Details

SectorHealthcare
IndustryMedical Care Facilities
CEOMr. Songyong Lian
Employees6.97K
HeadquartersUnit 1206, Shanghai, China, Germany
Websitehttps://www.beautyfarm.com.cn

Leadership

Mr. Yang LiExecutive Chairman · b. 1960
Mr. Songyong LianCEO & Vice-Chairman · b. 1972
Ms. Min ZhouCFO & Joint Company Secretary · b. 1970
Mr. Jingfeng LiuChief Operating Officer · b. 1980
Ms. Vivian LuInvestor Relations Director
Ms. Siu Ying KwokJoint Company Secretary · b. 1985

Financials

Income Statement

Currency: CNY	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	1.78B	1.64B	2.15B	2.57B	3.00B
Growth (%)	-	-8.16%	+31.16%	+19.91%	+16.65%
Cost of Revenue	946.95M	917.57M	1.17B	1.38B	1.53B
Gross Profit	833.79M	717.84M	977.10M	1.19B	1.47B
Gross Margin	46.82%	43.89%	45.55%	46.26%	49.05%
Operating Expense	579.10M	587.57M	711.21M	880.31M	1.02B
Operating Income	254.68M	130.27M	265.89M	309.69M	450.17M
Operating Margin	14.30%	7.97%	12.40%	12.04%	15.00%
EBITDA	-	452.43M	644.82M	728.02M	886.98M
EBITDA Margin	-	27.66%	30.06%	28.30%	29.56%
Net Income	193.47M	103.11M	215.66M	228.46M	317.56M
Net Income Margin	10.86%	6.30%	10.05%	8.88%	10.58%
R&D	18.03M	31.19M	34.07M	36.03M	41.94M
R&D as % of Total Revenue	1.01%	1.91%	1.59%	1.40%	1.40%
Interest Expense	24.22M	24.71M	24.81M	27.56M	32.16M
Interest Expense % of Total Revenue	1.36%	1.51%	1.16%	1.07%	1.07%

Balance Sheet

Currency: CNY	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	2.48B	2.50B	3.30B	4.28B	5.05B
Total Liabilities	2.21B	2.29B	2.47B	3.30B	3.98B
Total Equity	257.36M	188.75M	801.90M	944.64M	1.02B
Cash	157.28M	164.12M	224.28M	456.16M	1.11B

Cash Flow

Currency: CNY	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	669.93M	382.00M	625.51M	796.63M	999.09M
Capital Expenditure	133.17M	140.79M	159.24M	114.18M	67.08M
Free Cash Flow	536.76M	241.21M	466.27M	682.44M	932.01M
Dividends Paid	81.16M	204.26M	87.00M	112.49M	122.27M
FCF to OCF	80.12%	63.14%	74.54%	85.67%	93.29%
Dividend Paid to FCF	15.12%	84.68%	18.66%	16.48%	13.12%

Key Statistics & Ratios

Market Cap473.01M

Enterprise Value372.06M

Trailing P/E9.55

Forward P/E0.00

Price / Sales0.14

Price / Book2.64

EPS0.20

Book Value0.7504

Revenue (TTM)3.42B

Gross Profit (TTM)1.72B

EBITDA754.05M

Profit Margin11.22%

Operating Margin17.16%

Return on Equity34.13%

Return on Assets6.54%

Shares Outstanding247.65M

Shares Float58.81M

Beta1.32

Dividend Yield4.16%

Dividend Rate0.08

Payout Ratio30.08%

Dividends

20261×

0.08Aug 19, 2026

20251×

0.06Aug 19, 2025

20241×

0.05Jul 2, 2024

20231×

0.04Jun 21, 2023